Independent Financial Group LLC Acquires Shares of 3,790 Danaher Corporation $DHR

Independent Financial Group LLC bought a new stake in shares of Danaher Corporation (NYSE:DHR) in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm bought 3,790 shares of the conglomerate’s stock, valued at approximately $719,000.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Bank Pictet & Cie Europe AG raised its stake in shares of Danaher by 25.4% in the fourth quarter. Bank Pictet & Cie Europe AG now owns 366,481 shares of the conglomerate’s stock valued at $83,895,000 after buying an additional 74,301 shares during the period. Defender Capital LLC. bought a new position in shares of Danaher during the 4th quarter worth $35,715,000. Northwestern Mutual Wealth Management Co. increased its holdings in Danaher by 303.7% in the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 248,020 shares of the conglomerate’s stock worth $56,777,000 after acquiring an additional 186,584 shares during the last quarter. Peak Financial Advisors LLC increased its holdings in Danaher by 215.4% in the 4th quarter. Peak Financial Advisors LLC now owns 10,638 shares of the conglomerate’s stock worth $2,435,000 after acquiring an additional 7,265 shares during the last quarter. Finally, SeaBridge Investment Advisors LLC bought a new stake in Danaher in the 4th quarter valued at about $4,477,000. 79.05% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

DHR has been the topic of several recent research reports. Citigroup assumed coverage on shares of Danaher in a report on Tuesday, May 26th. They set a “buy” rating and a $230.00 price objective on the stock. Piper Sandler assumed coverage on shares of Danaher in a research report on Thursday, June 11th. They issued a “neutral” rating and a $200.00 price target on the stock. Jefferies Financial Group restated a “buy” rating and set a $245.00 price target on shares of Danaher in a research note on Tuesday, April 21st. Rothschild & Co Redburn set a $205.00 price target on shares of Danaher in a research note on Friday, April 17th. Finally, Evercore reaffirmed an “outperform” rating and issued a $230.00 price objective on shares of Danaher in a report on Monday, July 6th. One investment analyst has rated the stock with a Strong Buy rating, eighteen have issued a Buy rating and five have given a Hold rating to the company’s stock. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $231.64.

Danaher News Roundup

Here are the key news stories impacting Danaher this week:

• Positive Sentiment: Danaher posted Q2 adjusted EPS of $1.94, above the $1.84 consensus, and revenue of about $6.26 billion to $6.3 billion, also ahead of estimates. Danaher Reports Second Quarter 2026 Results
• Positive Sentiment: Management raised full-year adjusted EPS guidance, showing confidence in profitability despite the softer sales backdrop. Danaher Corp (DHR) Q2 2026 Earnings Call Highlights
• Neutral Sentiment: Life Sciences was a bright spot, with stronger sales growth, but bioprocessing revenue came in weaker than expected and was cited as a drag on sentiment. Reuters: Danaher’s revenue outlook cut, biotech miss overshadow profit forecast raise
• Negative Sentiment: Investors reacted negatively to the reduced core revenue growth outlook and cautious near-term guidance, which outweighed the earnings beat and led to the stock decline. Danaher stock slips despite Q2 earnings beat, raised guidance
• Negative Sentiment: Analysts also highlighted “surprisingly soft” bioprocessing sales, reinforcing concerns that growth may slow more than expected. Danaher Plummets After One Segment Comes In ‘Surprisingly Soft’

Danaher Trading Down 11.0%

Shares of Danaher stock opened at $179.01 on Wednesday. Danaher Corporation has a 12-month low of $160.93 and a 12-month high of $242.80. The company has a market cap of $126.70 billion, a price-to-earnings ratio of 34.62, a PEG ratio of 2.48 and a beta of 0.79. The company has a current ratio of 1.87, a quick ratio of 1.52 and a debt-to-equity ratio of 0.33. The company’s 50-day moving average price is $184.22 and its 200-day moving average price is $197.69.

Danaher (NYSE:DHR) last released its quarterly earnings data on Tuesday, July 21st. The conglomerate reported $1.94 EPS for the quarter, beating analysts’ consensus estimates of $1.84 by $0.10. The company had revenue of $6.26 billion during the quarter, compared to analyst estimates of $6.11 billion. Danaher had a net margin of 14.89% and a return on equity of 10.91%. Danaher’s revenue was up 5.5% compared to the same quarter last year. During the same period last year, the business earned $0.77 earnings per share. On average, equities analysts expect that Danaher Corporation will post 8.45 earnings per share for the current fiscal year.

Danaher Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, July 31st. Shareholders of record on Friday, June 26th will be issued a $0.40 dividend. This represents a $1.60 annualized dividend and a yield of 0.9%. The ex-dividend date of this dividend is Friday, June 26th. Danaher’s dividend payout ratio (DPR) is presently 30.95%.

Danaher Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.